A trio of scientists have started working with researchers at GlaxoSmitKline on a potential cure for cancer. In fact, they believe they’ve found the diseases’ “Achilles heel.”
Last month, GlaxoSmithKline (NYSE: GSK) selected a Wistar/Penn project for its 2014 Discovery Fast Track Challenge program, which was created to accelerate the development of new medicines.
{iframe}http://www.bizjournals.com/philadelphia/blog/health-care/2015/01/gsk-penn-wistar-partnership-takes-on-cancer.html{/iframe}